Modified oncolytic viruses

Details for Australian Patent Application No. 2005221725 (hide)

Owner Viralytics Limited

Inventors Shafren, Darren Raymond; Johansson, Eva Susanne

Agent Spruson & Ferguson

Pub. Number AU-B-2005221725

PCT Pub. Number WO2005/087931

Priority 60/552,095 11.03.04 US

Filing date 17 January 2005

Wipo publication date 22 September 2005

Acceptance publication date 24 June 2010

International Classifications

C12N 15/41 (2006.01) Mutation or genetic engineering

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

C07K 14/085 (2006.01) Peptides having more than 20 amino acids

C12N 9/50 (2006.01) Enzymes, e.g. ligases (6.) - Proteinases

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/087931 Priority application(s): WO2005/087931

26 July 2007 Assignment before Grant

  Virotarg Pty Ltd The application has been assigned to Viralytics Limited

24 June 2010 Application Accepted

  Published as AU-B-2005221725

21 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221726-Dispensing device

2005221717-Method for stimulating the immune, inflammatory or neuroprotective response